The looming threat of invasive fungal infections in heart transplant recipients: Will it be the last of us. [PDF]
Lowe A, King ST, Hand J.
europepmc +1 more source
When Should Clinical Mycology Laboratories Perform Antifungal Susceptibility Testing? Revisiting Practice Through the Lens of Intrinsic Resistance. [PDF]
Lass-Flörl C, Arikan-Akdagli S.
europepmc +1 more source
<i>In vitro</i> activity of novel antifungals, natamycin, and terbinafine against <i>Fusarium</i>. [PDF]
Garbe E +5 more
europepmc +1 more source
Discovery of Novel Inhibitors of <i>Aspergillus fumigatus</i> DHODH via Virtual Screening, MD Simulation, and In Vitro Activity Assay. [PDF]
Li K, Xia W, Zhang JZH.
europepmc +1 more source
Eumycetoma: pathogenesis, current treatments, and the search for new drugs. [PDF]
Yachioui DE +2 more
europepmc +1 more source
Scedosporium infection as a late complication after start of elexacaftor/tezacaftor/ivacaftor: two case reports. [PDF]
van Mourik P +6 more
europepmc +1 more source
Azole fungicides and Aspergillus resistance, five EU agency report highlights the problem for the first time using a One Health approach. [PDF]
Lackner M +5 more
europepmc +1 more source
Azole-Resistant <i>Aspergillus fumigatus</i>: Epidemiology, Diagnosis, and Treatment Considerations. [PDF]
Zubovskaia A.
europepmc +1 more source
Successful management of <i>Lomentospora prolificans</i> septic arthritis and osteomyelitis in an immunocompetent child: A case report. [PDF]
Johnston N +6 more
europepmc +1 more source
Trends of Azole-Resistant Aspergillus Fumigatus Susceptibility Over 12 Years from a German ECMM Excellence Center. [PDF]
Verhasselt HL +6 more
europepmc +1 more source

